LncRNA LUESCC promotes esophageal squamous cell carcinoma by targeting the miR-6785-5p/NRSN2 axis

Songtao Xue; Shi-qiang Cao; Jian‐cheng Ding; Wenjuan Li; Guo-Sheng Hu; Jian-cong Zheng; Xiao Lin; Chun Chen; Wen Liu; Bin Zheng

doi:10.1007/s00018-024-05172-9

ScienceGate Book Chapters

JOURNAL ARTICLE

LncRNA LUESCC promotes esophageal squamous cell carcinoma by targeting the miR-6785-5p/NRSN2 axis

Songtao Xue Shi-qiang Cao Jian‐cheng Ding Wenjuan Li Guo-Sheng Hu Jian-cong Zheng Xiao Lin Chun Chen Wen Liu Bin Zheng

Year: 2024 Journal: Cellular and Molecular Life Sciences Vol: 81 (1)Pages: 121-121 Publisher: Springer Nature

DOI: 10.1007/s00018-024-05172-9

Get Full-Text PDF Get Analytical Report

Keywords:

Gene knockdown Cancer research Competing endogenous RNA Downregulation and upregulation Biology In vivo Cell growth Long non-coding RNA Metastasis Cell Esophageal squamous cell carcinoma Cell migration In vitro Cancer Cell culture Gene Genetics

Metrics

Cited By

6.81

FWCI (Field Weighted Citation Impact)

Refs

0.94

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Cancer-related molecular mechanisms research

Life Sciences → Biochemistry, Genetics and Molecular Biology → Cancer Research

Circular RNAs in diseases

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

RNA modifications and cancer

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

LncRNA LUESCC promotes esophageal squamous cell carcinoma by targeting the miR-6785-5p/NRSN2 axis

Metrics

Citation History

Topics

Related Documents

LncRNA JPX Promotes Esophageal Squamous Cell Carcinoma Progression by Targeting miR-516b-5p/VEGFA Axis

LncRNA LOC146880 promotes esophageal squamous cell carcinoma progression via miR-328-5p/FSCN1/MAPK axis

LncRNA FER1L4 Promotes Oral Squamous Cell Carcinoma Progression via Targeting miR-133a-5p/Prx1 Axis

LncRNA PART1 promotes lung squamous cell carcinoma progression via miR-185-5p/Six1 axis

LncRNA-CASC15 knockdown inhibits the progression of esophageal squamous cell carcinoma through targeting miR-33a-5p/PTGS2 axis.